← ANALYSTS · TIPRANKS
Silvan Tuerkcan · Citizens JMP
Hits
43%
168 of 390 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+16.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
7
Buy / hold / sell: 5 / 2 / 0
Upside of the analyst’s targets
+144.5%
Average over 5 current targets, to the last price
The market’s answer to the ratings
+5.8%
Day-0 move against SPY in the rating’s direction, average over 7 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 1on TipRanks 14:55 | FHTXIWMFoghorn Therapeutics · $112M | Downgrade | Hold | — | — | −18.4%next day −31.6% · 5 days −33.2% | ↗ |
| Aug 10on TipRanks 06:00 | RLAYIWMRelay Therapeutics · $3.8B | Reiterated | Buy | $21.00 → $26.00+23.8% | +59.7% | +0.9%next day +0.6% · 5 days +3.7% | ↗ |
| Jun 23on TipRanks 05:50 | TSHAIWMTaysha Gene Therapies · $1.2B | Reiterated | Buy | $8.00 → $11.00+37.5% | +203.9% | +6.5%next day +1.2% · 5 days −2.5% | ↗ |
| May 8on TipRanks 05:05 | ENGNenGene Holdings · $115M | Downgrade | Hold | — | — | −13.6%next day −0.9% · 5 days +14.5% | ↗ |
| Apr 28on TipRanks 05:50 | NTLAIWMIntellia Therapeutics · $1.6B | Reiterated | Buy | $28.00 → $30.00+7.1% | +162.7% | +1.7%next day −5.7% · 5 days −0.9% | ↗ |
| Nov 20on TipRanks 06:30 | NUVBIWMNuvation Bio · $1.7B | Reiterated | Buy | $8.00 → $10.00+25.0% | +124.7% | −0.4%next day −1.3% · 5 days +9.8% | ↗ |
| Nov 4on TipRanks 06:55 | BNTCIWMBenitec Biopharma · $289M | Reiterated | Buy | $20.00 → $22.00+10.0% | +171.3% | +0.2%next day +0.1% · 5 days −16.7% | ↗ |
| Oct 31on TipRanks 03:32 | FHTXIWMFoghorn Therapeutics · $112M | Reiterated | Buy | $9.00 | +386.5% | +2.0%next day −4.7% · 5 days +0.5% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗